Immutep Ltd ADR (IMMP)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $25.64M
Last updated: Nov 17, 2026 at 10:55 AM ET
Immutep Ltd ADR (IMMP) Financials: Revenue, Profit and Cash Flow
Immutep Ltd ADR reported revenue of AUD 14.24M for the fiscal year ended Jun 30, 2026, up 182.3% from the year before. That year, net income was AUD -77.57M with a net margin of -544.8%, operating cash flow was AUD -54.25M and free cash flow was AUD -54.34M. The quarter ended Jun 30, 2026 had revenue of AUD 10.62M and net income of AUD -34.93M.
Revenue and Margins
Over the 9 years to Jun 2026, revenue grew from AUD 4.22M, a compound annual rate of 14.5%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Jun 2026 | 14.24M | +182.3% | 83.0% | -576.2% | -544.8% |
| Jun 2025 | 5.04M | +31.3% | -1117.6% | -2506.5% | -1218.0% |
| Jun 2024 | 3.84M | +9.6% | -981.4% | -2293.3% | -1111.9% |
| Jun 2023 | 3.51M | +1957.7% | 41.2% | -2216.0% | -1138.0% |
| Jun 2022 | 170.37K | -95.6% | -1111.2% | -19920.0% | -18906.5% |
| Jun 2021 | 3.86M | -48.4% | -346.2% | -820.0% | -774.1% |
| Jun 2020 | 7.49M | +5255.8% | -200.2% | -214.0% | -179.9% |
| Jun 2019 | 139.78K | -94.7% | -11769.3% | -14606.5% | -11640.0% |
| Jun 2018 | 2.63M | -37.7% | -279.8% | -444.5% | -484.6% |
| Jun 2017 | 4.22M | N/A | 59.7% | -221.5% | -221.9% |
Income Statement
In the fiscal year ended Jun 2026, the net loss widened from the year before. In the quarter ended Jun 2026, the net loss narrowed from the same quarter a year earlier.
Annual
| Line item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14.24M | 5.04M | 3.84M | 3.51M | 170.37K | 3.86M | 7.49M | 139.78K | 2.63M | 4.22M |
| Cost of revenue | 2.42M | 61.41M | 41.55M | 2.06M | 2.06M | 17.24M | 22.47M | 16.59M | 9.99M | 1.70M |
| Gross profit | 11.82M | -56.37M | -37.70M | 1.44M | -1.89M | -13.37M | -14.99M | -16.45M | -7.36M | 2.52M |
| Research and development | 74.98M | 61.41M | 41.55M | 28.79M | 31.34M | 17.24M | 20.40M | 16.59M | 9.99M | 7.53M |
| Operating income | -82.05M | -126.42M | -88.10M | -77.69M | -33.94M | -31.68M | -16.02M | -20.42M | -11.69M | -9.35M |
| Net income | -77.57M | -61.43M | -42.72M | -39.90M | -32.21M | -29.90M | -13.47M | -16.27M | -12.75M | -9.37M |
| EBITDA | -79.63M | -62.52M | -44.39M | -39.40M | -31.77M | N/A | -11.38M | -16.46M | -10.38M | -8.40M |
Quarterly
| Line item | Jun 2026 | Dec 2025 | Jun 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10.62M | 6.03M | 1.90M | 3.15M | 1.73M | 1.73M | 2.11M | 1.82M | N/A | N/A | 1.69M | 170.37K |
| Gross profit | 9.55M | -40.60M | -34.18M | -22.18M | -19.38M | -19.38M | 1.11M | 896.17K | N/A | N/A | 750.34K | -946.33K |
| Operating income | -39.55M | -46.03M | -74.67M | -51.75M | -44.54M | -44.54M | -43.56M | -21.83M | N/A | N/A | -23.11M | -19.46M |
| Net income | -34.93M | -44.86M | -39.06M | -22.38M | -21.49M | -21.49M | -21.23M | -19.27M | N/A | N/A | -20.62M | -15.94M |
Balance Sheet
As of Jun 2026, cash and equivalents exceeded short-term debt of AUD 290.17K by 68.59M.
Annual
| Line item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 83.27M | 156.98M | 201.58M | 147.45M | 102.17M | 82.03M | 46.60M | 40.54M | 47.00M | 34.96M |
| Current assets | 80.63M | 149.10M | 191.35M | 134.97M | 90.81M | 68.42M | 31.15M | 23.54M | 28.64M | 15.92M |
| Cash and equivalents | 68.88M | 67.41M | 161.79M | 123.42M | 80.00M | 60.13M | 26.32M | 16.57M | 23.48M | 12.24M |
| Total liabilities | 21.74M | 13.35M | 12.06M | 10.98M | 8.09M | 8.76M | 13.30M | 16.15M | 13.48M | 8.43M |
| Short-term debt | 290.17K | 1.31M | 233.62K | 185.21K | 173.38K | 416.39K | 129.41K | 0 | 0 | 0 |
| Long-term debt | N/A | N/A | 960.76K | 835.45K | N/A | 2.53M | 8.79M | 7.64M | 6.65M | 5.78M |
| Shareholder equity | 61.54M | 143.64M | 189.52M | 136.47M | 94.08M | 73.27M | 33.30M | 24.39M | 33.52M | 26.53M |
Quarterly
| Line item | Jun 2026 | Dec 2025 | Jun 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 83.27M | 147.20M | 156.98M | 182.33M | 201.58M | 201.58M | 123.79M | 147.45M | 147.45M | N/A | 86.01M | 102.17M |
| Total liabilities | 21.74M | 48.30M | 13.35M | 9.86M | 12.06M | 12.06M | 8.15M | 10.98M | 10.98M | N/A | 9.32M | 8.09M |
| Cash and equivalents | 68.88M | 72.75M | 67.41M | 73.89M | 161.79M | 161.79M | 103.73M | 123.42M | 123.42M | N/A | 68.38M | 80.00M |
| Shareholder equity | 61.54M | 98.90M | 143.64M | 172.47M | 189.52M | 189.52M | 115.64M | 136.47M | 136.47M | N/A | 76.69M | 94.08M |
Cash Flow
Operating cash flow was negative in the fiscal year ended Jun 2026.
Annual
| Line item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -54.25M | -62.05M | -34.82M | -35.88M | -30.23M | -17.64M | -10.84M | -15.29M | -7.78M | -8.51M |
| Capital expenditures | 90.89K | 45.77K | 932.37K | 47.00K | 22.91K | 15.60K | 19.35K | 41.43K | 11.89K | 6.64K |
| Free cash flow | -54.34M | -62.10M | -35.75M | -35.93M | -30.25M | -17.66M | -10.86M | -15.33M | -7.79M | -8.51M |
| Investing cash flow | 55.23M | -38.53M | -21.02M | -31.00K | -22.91K | -15.60K | -19.35K | -41.43K | -11.89K | -6.64K |
| Financing cash flow | -209.74K | -525.12K | 95.18M | 76.04M | 50.33M | 52.68M | 20.48M | 8.01M | 18.40M | -8.53K |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -29.15M | N/A | -28.12M | -33.50M | N/A | -28.55M | -7.49M | -16.37M | N/A | -17.41M | -17.94M | -8.35M |
| Capital expenditures | 6.60K | 5.00K | 90.96K | 34.27K | 50.09K | 11.50K | N/A | 12.40K | 538.00K | N/A | 23.50K | 3.00K |
| Free cash flow | -29.15M | N/A | -28.21M | -33.54M | N/A | -28.56M | N/A | -16.38M | N/A | N/A | -17.96M | -8.35M |
Frequently Asked Questions About IMMP
What is Immutep Ltd ADR's annual revenue?
Immutep Ltd ADR reported revenue of AUD 14.24M for the fiscal year ended Jun 30, 2026.
How fast is Immutep Ltd ADR's revenue growing?
Revenue was up 182.3% for the fiscal year ended Jun 30, 2026 compared with the year before. The compound annual revenue growth rate over 3 years was 59.6%.
Is Immutep Ltd ADR profitable?
No. Immutep Ltd ADR reported net income of AUD -77.57M for the fiscal year ended Jun 30, 2026, with a net margin of -544.8%.
How much free cash flow does IMMP generate?
For the fiscal year ended Jun 30, 2026, operating cash flow of AUD -54.25M minus capital expenditures of AUD 90.89K produced free cash flow of AUD -54.34M.
How much debt does Immutep Ltd ADR have?
The balance sheet dated Jun 30, 2026 reported short-term debt of AUD 290.17K and cash and equivalents of AUD 68.88M.
IMMP pages: Overview, Financials